Zhuoxiao Cao, PhD

Chief Operations Officer

Zhuoxiao Cao, PhD

Dr. Zhuoxiao Cao has been working on innovative drug development of biologics for more than 12 years in various disease areas, including oncology and autoimmune diseases. Prior to joining SimnovaBio, Dr. Cao worked at Novo Nordisk, Shanghai Hengrui and Simcere Pharmaceuticals with comprehensive experience in technology platforms and delivering novel drug leads.

Dr. Cao also has extensive preclinical experience in target validation, lead identification, CMC, to IND enabling for which several products are currently in clinical development stage. In recent years she has been heavily involved in the field of the R&D of Cell Therapy possessing deep expertise.

Dr. Cao received her MD from Shanxi Medical University in China and obtained a PhD in Pharmacology and Toxicology at St John’s University in the US. Dr Cao’s Postdoctoral Research was conducted at Harvard Medical School where she focused on cardiovascular diseases and inflammation.